{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:17:56Z","timestamp":1767179876768,"version":"build-2238731810"},"reference-count":84,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142911","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T14:02:08Z","timestamp":1447423328000},"page":"e0142911","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer"],"prefix":"10.1371","volume":"10","author":[{"given":"Mich\u00e8l","family":"Schummer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Giraldez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Bergan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneesh","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,13]]},"reference":[{"key":"ref1","unstructured":"American Cancer Society. Global Cancer Facts and Figures 2012. 2012."},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref3","article-title":"SEER Cancer Statistics Review, 1975\u20132008"},{"issue":"9310","key":"ref4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","article-title":"Long-term effects of mammography screening: updated overview of the Swedish randomised trials","volume":"359","author":"L Nystr\u00f6m","year":"2002","journal-title":"Lancet"},{"issue":"21","key":"ref5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"A Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"20","key":"ref6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/jnci\/djt268","article-title":"Ductal carcinoma in situ: a rose by any other name","volume":"105","author":"DL Wickerham","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2214\/AJR.10.5442","article-title":"Accuracy of screening mammography in older women","volume":"197","author":"N Sinclair","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"W292","DOI":"10.2214\/AJR.10.6049","article-title":"The relationship of mammographic density and age: implications for breast cancer screening","volume":"198","author":"CM Checka","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"33","key":"ref9","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"25","author":"L Harris","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000089260","article-title":"Tumor markers in breast cancer- European Group on Tumor Markers recommendations","volume":"26","author":"R Molina","year":"2005","journal-title":"Tumour Biol"},{"issue":"6797","key":"ref11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"issue":"27","key":"ref12","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"S Paik","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/bcr562","article-title":"Expression profiling predicts outcome in breast cancer","volume":"5","author":"L van 't Veer","year":"2003","journal-title":"Breast Cancer Res"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1158\/0008-5472.CAN-11-3711","article-title":"Proteomic portrait of human breast cancer progression identifies novel prognostic markers","volume":"72","author":"T Geiger","year":"2012","journal-title":"Cancer Res"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nmeth.2763","article-title":"Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins","volume":"11","author":"JJ Kennedy","year":"2014","journal-title":"Nat Methods"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr2841","article-title":"Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis","volume":"13","author":"O Blixt","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/bjc.2013.214","article-title":"Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer","volume":"108","author":"B Burford","year":"2013","journal-title":"Br J Cancer"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2004.12.017","article-title":"Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis","volume":"230","author":"Madrid F Fern\u00e1ndez","year":"2005","journal-title":"Cancer Lett"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1074\/mcp.R600010-MCP200","article-title":"Tumor-associated antigen arrays for the serological diagnosis of cancer","volume":"5","author":"CA Casiano","year":"2006","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"ref20","first-page":"973","article-title":"Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers","volume":"29","author":"M M\u00fcller","year":"2006","journal-title":"Int J Oncol"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/1940-6207.CAPR-11-0558","article-title":"Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera","volume":"5","author":"H Lu","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review","volume":"66","author":"S Ferraro","year":"2013","journal-title":"J Clin Pathol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","article-title":"Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas","volume":"238","author":"M Schummer","year":"1999","journal-title":"Gene"},{"issue":"13","key":"ref24","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"I Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","article-title":"Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens","volume":"4","author":"DW Cramer","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref26","article-title":"Comprehensive molecular portraits of human breast tumours","author":"DC Koboldt","year":"2012","journal-title":"Nature"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"e107643","DOI":"10.1371\/journal.pone.0107643","article-title":"Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes","volume":"9","author":"JM J\u00f6nsson","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"e9122","DOI":"10.1371\/journal.pone.0009122","article-title":"Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection","volume":"5","author":"M Schummer","year":"2010","journal-title":"PLoS ONE"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/gb-2007-8-10-r214","article-title":"MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype","volume":"8","author":"C Blenkiron","year":"2007","journal-title":"Genome Biol"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2257","article-title":"MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer","volume":"11","author":"AJ Lowery","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"e16915","DOI":"10.1371\/journal.pone.0016915","article-title":"miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors","volume":"6","author":"E Enerly","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","article-title":"Molecular characterization of basal-like and non-basal-like triple-negative breast cancer","volume":"18","author":"A Prat","year":"2013","journal-title":"Oncologist"},{"issue":"15","key":"ref33","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"R Dent","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"20","key":"ref34","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"WD Foulkes","year":"2010","journal-title":"N Engl J Med"},{"issue":"4785","key":"ref35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"DJ Slamon","year":"1987","journal-title":"Science"},{"issue":"13","key":"ref36","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1200\/JCO.2006.09.2106","article-title":"Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis","volume":"25","author":"I Jatoi","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref37","unstructured":"Schwartz SM, Li CI, Potts M, Hafterson J. Cancer Surveillance System 2014 [cited 2014 2014-11-20]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fredhutch.org\/en\/labs\/phs\/projects\/cancer-surveillance-system.html\" xlink:type=\"simple\">http:\/\/www.fredhutch.org\/en\/labs\/phs\/projects\/cancer-surveillance-system.html<\/ext-link>."},{"issue":"10","key":"ref38","first-page":"12091","article-title":"Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma","volume":"26","author":"CZ Yang","year":"2013","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000328963","article-title":"Diagnostic validity of serum macrophage inhibitor cytokine and tissue polypeptide-specific antigen in pancreatobiliary diseases","volume":"11","author":"H \u00d6zkan","year":"2011","journal-title":"Pancreatology"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-11-0786","article-title":"Serum macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a potential screening tool for the prevention of colon cancer?","volume":"21","author":"DA Brown","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1\u20132","key":"ref41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3835(02)00404-4","article-title":"Tumor M2 pyruvate kinase\u2014determination in breast cancer patients receiving trastuzumab therapy","volume":"187","author":"M Hoopmann","year":"2002","journal-title":"Cancer Lett"},{"issue":"6D","key":"ref42","first-page":"5077","article-title":"Tumor type M2 pyruvate kinase expression in advanced breast cancer","volume":"20","author":"D L\u00fcftner","year":"2000","journal-title":"Anticancer Res"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-010-0867-2","article-title":"Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients","volume":"126","author":"MA Nagai","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000050620","article-title":"Elevated CA125 in breast cancer\u2014A sign of advanced disease","volume":"22","author":"LF Norum","year":"2001","journal-title":"Tumour Biol"},{"key":"ref45","article-title":"Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease","volume":"3","author":"JR Marks","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1515\/cclm-2012-0097","article-title":"Human epididymis protein 4 (HE4) in benign and malignant diseases","volume":"50","author":"L Hertlein","year":"2012","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"ref47","first-page":"4779","article-title":"HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer","volume":"30","author":"M Kamei","year":"2010","journal-title":"Anticancer Res"},{"issue":"14","key":"ref48","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"T S\u00f8rlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"R499","DOI":"10.1186\/bcr899","article-title":"Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression","volume":"6","author":"MC Abba","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-03-2361","article-title":"Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes","volume":"64","author":"S Amatschek","year":"2004","journal-title":"Cancer Res"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1091\/mbc.E03-11-0786","article-title":"Different gene expression patterns in invasive lobular and ductal carcinomas of the breast","volume":"15","author":"H Zhao","year":"2004","journal-title":"Mol Biol Cell"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2407-7-55","article-title":"Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis","volume":"7","author":"G Turashvili","year":"2007","journal-title":"BMC Cancer"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000123849","article-title":"Lost in translation? A systematic database of gene expression in breast cancer","volume":"75","author":"N Srour","year":"2008","journal-title":"Pathobiology"},{"issue":"17","key":"ref54","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1158\/1078-0432.CCR-08-0555","article-title":"Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response","volume":"14","author":"J Helleman","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2581","article-title":"Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation","volume":"219","author":"CB Westbury","year":"2009","journal-title":"J Pathol"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/bcr1604","article-title":"Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data","volume":"8","author":"A Grigoriadis","year":"2006","journal-title":"Breast Cancer Res"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"e1741","DOI":"10.1371\/journal.pone.0001741","article-title":"S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation","volume":"3","author":"V Paruchuri","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1016339120506","article-title":"Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR","volume":"74","author":"MM Reinholz","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ijc.23204","article-title":"Osteopontin-c is a selective marker of breast cancer","volume":"122","author":"M Mirza","year":"2008","journal-title":"Int J Cancer"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based Human Protein Atlas","volume":"28","author":"M Uhl\u00e9n","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1755-1536-5-S1-S8","article-title":"Connective tissue growth factor in tumor pathogenesis","volume":"5","author":"A Jacobson","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1021\/pr700748m","article-title":"New protein clustering of breast cancer tissue proteomics using actin content as a cellularity indicator","volume":"7","author":"I Pucci-Minafra","year":"2008","journal-title":"J Proteome Res"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1078-0432.CCR-1405-2","article-title":"Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies","volume":"10","author":"D Coppola","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2362.2008.01956.x","article-title":"Increased expression of osteopontin in patients with triple-negative breast cancer","volume":"38","author":"X Wang","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cca.2013.02.029","article-title":"Connective tissue growth factor (CTGF\/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection","volume":"421","author":"OA Gressner","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2133.2008.08904.x","article-title":"Detection of psoriasin\/S100A7 in the sera of patients with psoriasis","volume":"160","author":"KS Anderson","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jprot.2012.11.004","article-title":"A mass spectrometry-based plasma protein panel targeting the tumor microenvironment in patients with breast cancer","volume":"81","author":"A Cohen","year":"2013","journal-title":"J Proteomics"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/sj.bjc.6605511","article-title":"Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening","volume":"102","author":"E Ruiz-Garcia","year":"2010","journal-title":"Br J Cancer"},{"issue":"60","key":"ref69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1479-5876-7-60","article-title":"Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer","volume":"7","author":"M Pietrowska","year":"2009","journal-title":"Journal of Translational Medicine"},{"issue":"11","key":"ref70","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/1078-0432.CCR-05-2354","article-title":"Serial plasma osteopontin levels have prognostic value in metastatic breast cancer","volume":"12","author":"VH Bramwell","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"10","key":"ref71","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.3390\/ijms131013587","article-title":"A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum","volume":"13","author":"AW Opstal-van Winden","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"2","key":"ref72","first-page":"285","article-title":"Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer","volume":"7","author":"Y Niwa","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"7","key":"ref73","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1055-9965.EPI-10-1248","article-title":"Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased","volume":"20","author":"RM Gonzalez","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12282-010-0244-3","article-title":"Serum appearance of anti-p53 antibody in triple negative breast cancer","volume":"19","author":"T Nozoe","year":"2012","journal-title":"Breast Cancer"},{"issue":"5\u20136","key":"ref75","first-page":"305","article-title":"Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors","volume":"28","author":"GS Henderson","year":"2006","journal-title":"Cell Oncol"},{"issue":"1","key":"ref76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-012-2123-4","article-title":"Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression","volume":"135","author":"AC Vargas","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"ref77","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"EM Kroh","year":"2010","journal-title":"Methods"},{"issue":"7","key":"ref78","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/1078-0432.CCR-05-2007","article-title":"Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers","volume":"12","author":"N Scholler","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref79","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-21706-2","article-title":"Modern Applied Statistics with S","author":"WN Venables","year":"2002"},{"key":"ref80","article-title":"R: A Language and Environment for Statistical Computing","year":"2010"},{"issue":"3","key":"ref81","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2011.05.039","article-title":"Comparison of candidate serologic markers for type I and type II ovarian cancer","volume":"122","author":"D Lu","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"ref82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910300404","article-title":"Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer","volume":"30","author":"LV Crawford","year":"1982","journal-title":"Int J Cancer"},{"issue":"11","key":"ref83","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1373\/clinchem.2007.091371","article-title":"The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: implications for analyzing samples stored in serum banks","volume":"53","author":"T M\u00e4nnist\u00f6","year":"2007","journal-title":"Clin Chem"},{"issue":"2","key":"ref84","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S0029665112000158","article-title":"The impact of obesity on the immune response to infection","volume":"71","author":"JJ Milner","year":"2012","journal-title":"Proc Nutr Soc"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0147561","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:41:00Z","timestamp":1540024860000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142911"}},"subtitle":[],"editor":[{"given":"Vince","family":"Grolmusz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,13]]},"references-count":84,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142911","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,13]]}}}